Brief: Sangamo Therapeutics Q1 Operating Income USD -51.526 Million
May 09 (Reuters) - Sangamo Therapeutics Q1 net income USD -49.089 million. * Q1 adjusted operating expenses USD 43.6 million * Q1 operating expenses USD 52 million * Q1 revenue USD 481 thousand vs. IBES estimate USD 6.65 million